Gilead Sciences (GILD) Deferred Taxes (2009 - 2026)
Gilead Sciences posted quarterly Deferred Taxes of $179.0 million for Q1 2026, up 189.95% year-on-year from $61.7 million in Q1 2025, and up 246.72% on a QoQ basis from -$122.0 million in Q4 2025.
Gilead Sciences (GILD) has 18 years of Deferred Taxes data on file, last reported at $179.0 million in Q1 2026.
- For the quarter ending Q1 2026, Deferred Taxes rose 189.95% year-over-year to $179.0 million; the trailing twelve-month figure through Mar 2026 stood at $538.0 million (up 140.76% YoY), and the FY2025 full-year result was $160.0 million, up 108.68% from the prior year.
- Deferred Taxes for Q1 2026 stood at $179.0 million, up from -$122.0 million in the prior quarter.
- Across five years, Deferred Taxes topped out at $659.0 million in Q3 2025 and bottomed at -$723.0 million in Q1 2024.
- The 5-year median for Deferred Taxes is -$270.0 million (2022), against an average of -$236.4 million.
- The widest annual swing landed in 2022, when Deferred Taxes sank 1016.9%; it then surged 214.41% in 2025.
- A 5-year view of Deferred Taxes shows it stood at -$338.0 million in 2022, then dropped by 9.47% to -$370.0 million in 2023, then decreased by 2.43% to -$379.0 million in 2024, then jumped by 67.81% to -$122.0 million in 2025, then soared by 246.72% to $179.0 million in 2026.
- The last three Deferred Taxes figures came in at $179.0 million (Q1 2026), -$122.0 million (Q4 2025), and $659.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn | 1.48 Bn |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn | 159.00 Mn |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn | 137.00 Mn |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn | -315.00 Mn |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn | -176.00 Mn |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn | 179.00 Mn |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn | -12.00 Mn |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn | 161.00 Mn |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 179.00 Mn |
| Dec 31, 2025 | -122.00 Mn |
| Sep 30, 2025 | 659.00 Mn |
| Jun 30, 2025 | -178.00 Mn |
| Mar 31, 2025 | -199.00 Mn |
| Dec 31, 2024 | -379.00 Mn |
| Sep 30, 2024 | -576.00 Mn |
| Jun 30, 2024 | -166.00 Mn |
| Mar 31, 2024 | -723.00 Mn |
| Dec 31, 2023 | -370.00 Mn |
| Sep 30, 2023 | -68.00 Mn |
| Jun 30, 2023 | -221.00 Mn |
| Mar 31, 2023 | -303.00 Mn |
| Dec 31, 2022 | -338.00 Mn |
| Sep 30, 2022 | -270.00 Mn |
| Jun 30, 2022 | -293.00 Mn |
| Mar 31, 2022 | -651.00 Mn |
| Dec 31, 2021 | -359.00 Mn |
| Sep 30, 2021 | 240.00 Mn |
| Jun 30, 2021 | -68.00 Mn |
| Mar 31, 2021 | 71.00 Mn |
| Dec 31, 2020 | -202.00 Mn |
| Sep 30, 2020 | -121.00 Mn |
| Jun 30, 2020 | 53.00 Mn |
| Mar 31, 2020 | 56.00 Mn |
| Dec 31, 2019 | 2.89 Bn |
| Sep 30, 2019 | -824.00 Mn |
| Jun 30, 2019 | 4.00 Mn |
| Mar 31, 2019 | 24.00 Mn |
| Dec 31, 2018 | -299.00 Mn |
| Sep 30, 2018 | 12.00 Mn |
| Jun 30, 2018 | -37.00 Mn |
| Mar 31, 2018 | 35.00 Mn |
| Dec 31, 2017 | -45.00 Mn |
| Sep 30, 2017 | -11.00 Mn |
| Jun 30, 2017 | 80.00 Mn |
| Mar 31, 2017 | 58.00 Mn |
| Dec 31, 2016 | 214.00 Mn |
| Sep 30, 2016 | 21.00 Mn |
| Jun 30, 2016 | -131.00 Mn |
| Mar 31, 2016 | 15.00 Mn |
| Dec 31, 2015 | -49.00 Mn |
| Sep 30, 2015 | 182.00 Mn |
| Jun 30, 2015 | 139.00 Mn |
| Mar 31, 2015 | 121.00 Mn |
| Dec 31, 2014 | 169.00 Mn |
| Sep 30, 2014 | 14.00 Mn |
| Jun 30, 2014 | 50.00 Mn |
| Mar 31, 2014 | 3.00 Mn |
| Dec 31, 2013 | 85.60 Mn |
| Sep 30, 2013 | 22.37 Mn |
| Jun 30, 2013 | 29.33 Mn |
| Mar 31, 2013 | -39.30 Mn |
| Dec 31, 2012 | 60.37 Mn |
| Sep 30, 2012 | 592,000.00 |
| Jun 30, 2012 | 29.42 Mn |
| Mar 31, 2012 | -51.39 Mn |
| Dec 31, 2011 | -20.65 Mn |
| Sep 30, 2011 | -3.41 Mn |
| Jun 30, 2011 | -19.46 Mn |
| Mar 31, 2011 | -20.55 Mn |
| Dec 31, 2010 | 30.57 Mn |
| Sep 30, 2010 | -72.62 Mn |
| Jun 30, 2010 | -1.16 Mn |
| Mar 31, 2010 | 31.06 Mn |
| Dec 31, 2009 | 30.67 Mn |
| Sep 30, 2009 | -9.07 Mn |
| Jun 30, 2009 | 9.10 Mn |
| Mar 31, 2009 | 11.31 Mn |